Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Miteva

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Drug Discovery Today|November 8, 2011
Toward in silico structure-based ADMET prediction in drug discoveryGautier Moroy, Virginie Y Martiny, Philippe Vayer, et al.
Bioorganic & Medicinal Chemistry|June 26, 2014
Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screeningAnna Starzec, Maria A Miteva, Patrick Ladam, et al.
Nucleic Acids Research|July 18, 2006
FAF-Drugs: free ADME/tox filtering of compound collectionsMaria A Miteva, Stephanie Violas, Matthieu Montes, et al.
Oncotarget|September 8, 2018
Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targetsNathalie Lagarde, Julien Rey, Aram Gyulkhandanyan, et al.
Drug Discovery Today|September 12, 2022
Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolismAdriana Isvoran, Yunhui Peng, Silvana Ceauranu, et al.
Scientific Reports|June 24, 2021
Insights into the substrate binding mechanism of SULT1A1 through molecular dynamics with excited normal modes simulationsBalint Dudas, Daniel Toth, David Perahia, et al.
Plos One|June 25, 2011
Tyrosine kinase syk non-enzymatic inhibitors and potential anti-allergic drug-like compounds discovered by virtual and in vitro screeningBruno O Villoutreix, Guillaume Laconde, David Lagorce, et al.
Current Protein & Peptide Science|August 19, 2007
Free resources to assist structure-based virtual ligand screening experimentsBruno O Villoutreix, Nicolas Renault, David Lagorce, et al.
The Open Biochemistry Journal|October 25, 2008
Screening Outside the Catalytic Site: Inhibition of Macromolecular Inter-actions Through Structure-Based Virtual Ligand Screening ExperimentsOlivier Sperandio, Maria A Miteva, Kenneth Segers, et al.
European Biophysics Journal : EBJ|March 19, 2010
How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysisOlivier Sperandio, Liliane Mouawad, Eulalie Pinto, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Drug Discovery Today|November 8, 2011
Toward in silico structure-based ADMET prediction in drug discoveryGautier Moroy, Virginie Y Martiny, Philippe Vayer, et al.
Bioorganic & Medicinal Chemistry|June 26, 2014
Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screeningAnna Starzec, Maria A Miteva, Patrick Ladam, et al.
Nucleic Acids Research|July 18, 2006
FAF-Drugs: free ADME/tox filtering of compound collectionsMaria A Miteva, Stephanie Violas, Matthieu Montes, et al.
Oncotarget|September 8, 2018
Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targetsNathalie Lagarde, Julien Rey, Aram Gyulkhandanyan, et al.
Drug Discovery Today|September 12, 2022
Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolismAdriana Isvoran, Yunhui Peng, Silvana Ceauranu, et al.
Scientific Reports|June 24, 2021
Insights into the substrate binding mechanism of SULT1A1 through molecular dynamics with excited normal modes simulationsBalint Dudas, Daniel Toth, David Perahia, et al.
Plos One|June 25, 2011
Tyrosine kinase syk non-enzymatic inhibitors and potential anti-allergic drug-like compounds discovered by virtual and in vitro screeningBruno O Villoutreix, Guillaume Laconde, David Lagorce, et al.
Current Protein & Peptide Science|August 19, 2007
Free resources to assist structure-based virtual ligand screening experimentsBruno O Villoutreix, Nicolas Renault, David Lagorce, et al.
The Open Biochemistry Journal|October 25, 2008
Screening Outside the Catalytic Site: Inhibition of Macromolecular Inter-actions Through Structure-Based Virtual Ligand Screening ExperimentsOlivier Sperandio, Maria A Miteva, Kenneth Segers, et al.
European Biophysics Journal : EBJ|March 19, 2010
How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysisOlivier Sperandio, Liliane Mouawad, Eulalie Pinto, et al.
Pageof 9